U.S. Telehealth Execs Accused Of $100-M Adderall Scam

US investigators have arrested Ruthia He, the founder and CEO of telehealth company Done, and David Brody, the company's clinical president, for allegedly running a $100-million scheme to fraudulently distribute over 40 million pills of Adderall and other controlled substances.

The executives reportedly exploited telemedicine rules loosened during the COVID pandemic to provide easy access to Adderall and other stimulants without legitimate medical purposes.

Max Matza reported for BBC News that US Attorney General Merrick Garland stated that the executives exploited telemedicine rules loosened during the COVID pandemic to provide easy access to Adderall and other stimulants without legitimate medical purposes.

Done Global, based in San Francisco, gained popularity during the pandemic by offering Adderall through a monthly subscription service.

He and Brody are charged with distribution of controlled substances and could each face up to 20 years in prison if found guilty. The charges come amid a national shortage of Adderall, a medication used to manage ADHD symptoms.